The Development of Breast Cancer-Related Lymphedema After Mastectomy in a Rural Population.
Devin J CleggErica N WhiteakerBrett J SalomonAshton J BrooksJohn L BellStefanos BoukovalasPatricia N E RobersonJillian M LloydPublished in: The American surgeon (2023)
Breast cancer-related lymphedema (BCRL) is a lifelong condition that can impact the quality of life, affecting approximately 20% of breast cancer patients. Risk factors for the development of BCRL after mastectomy in rural populations have not been studied.Retrospective review of mastectomy patients from 2017 to 2021 was performed at a single institution. Statistical analysis included logistic and linear regression models.475 patients were included, and 40 (8.4%) patients were diagnosed with BCRL. Increased odds of developing BCRL were significantly associated with tumor-involved lymph nodes, radiation therapy, axillary lymphadenectomy, adjuvant chemotherapy, and endocrine therapy. Postmastectomy reconstruction significantly reduced the odds of developing BCRL. There was no significant association in our population with age, body mass index, diabetes, tobacco use, cancer type, or complications.This study demonstrates that individuals underrepresented in the literature, such as patients in largely rural communities, have some differences in risk factors for developing BCRL when compared to national studies.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- lymph node
- newly diagnosed
- radiation therapy
- prognostic factors
- peritoneal dialysis
- south africa
- squamous cell carcinoma
- systematic review
- metabolic syndrome
- patient reported outcomes
- physical activity
- adipose tissue
- risk factors
- young adults
- genetic diversity
- breast cancer risk